首页> 美国卫生研究院文献>Journal of Virology >Identification of Dominant Optimal HLA-B60- and HLA-B61-Restricted Cytotoxic T-Lymphocyte (CTL) Epitopes: Rapid Characterization of CTL Responses by Enzyme-Linked Immunospot Assay
【2h】

Identification of Dominant Optimal HLA-B60- and HLA-B61-Restricted Cytotoxic T-Lymphocyte (CTL) Epitopes: Rapid Characterization of CTL Responses by Enzyme-Linked Immunospot Assay

机译:主要的最佳HLA-B60和HLA-B61限制性细胞毒性T淋巴细胞(CTL)表位的鉴定:通过酶联免疫斑点法快速鉴定CTL反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte (CTL) responses play a major role in the antiviral immune response, but the relative contribution of CTL responses restricted by different HLA class I molecules is less well defined. HLA-B60 or the related allele B61 is expressed in 10 to 20% of Caucasoid populations and is even more highly prevalent in Asian populations, but yet no CTL epitopes restricted by these alleles have been defined. Here we report the definition of five novel HLA-B60-restricted HIV-1-specific CTL epitopes, using peripheral blood mononuclear cells in enzyme-linked immunospot (Elispot) assays and using CTL clones and lines in cytolytic assays. The dominant HLA-B60-restricted epitope, Nef peptide KEKGGLEGL, was targeted by all eight subjects with B60 and also by both subjects with B61 studied. This study additionally establishes the utility of the Elispot assay as a more rapid and efficient method of defining novel CTL epitopes. This approach will help to define new CTL epitopes that may play an important role in the immune control of HIV-1.
机译:人类1型免疫缺陷病毒(HIV-1)特异性细胞毒性T淋巴细胞(CTL)应答在抗病毒免疫应答中起主要作用,但受不同的I类HLA分子限制的CTL应答的相对贡献尚不清楚。 HLA-B60或相关等位基因B61在高加索地区的人口中占10%至20%,在亚洲人口中更为普遍,但尚未定义受这些等位基因限制的CTL表位。在这里,我们报告五个新的HLA-B60限制性HIV-1特异性CTL表位的定义,在酶联免疫斑点(Elispot)分析中使用外周血单个核细胞,在溶细胞分析中使用CTL克隆和品系。主要的HLA-B60限制性抗原决定簇,Nef肽KEKGGLEGL,已被所有接受B60治疗的八名受试者以及接受研究的B61两名受试者靶向。这项研究还确立了Elispot分析作为定义新型CTL表位的更快速有效的方法的实用性。这种方法将有助于定义可能在HIV-1免疫控制中发挥重要作用的新CTL表位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号